{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-048658","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.265576+00:00","generated_at":"2026-06-03T06:38:39.974082+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Renalytix closes second tranche of private placement, raises ~$7M gross","bullets":["Second Tranche of 26,815,841 ordinary shares at £0.20 each closed on April 24, 2024, following shareholder approval.","Gross proceeds from Second Tranche ~$7M; net proceeds expected to extend cash runway into calendar Q4 2024.","Post-issuance total ordinary shares outstanding: 154,368,191.","Company to file resale registration statement with SEC within 45 days of Second Closing.","First Tranche of 19,986,031 shares closed March 14, 2024; combined offering proceeds extend runway."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-048658","json":"https://secwatch.observer/filing/0000950170-24-048658.json","markdown":"https://secwatch.observer/filing/0000950170-24-048658.md","text":"https://secwatch.observer/filing/0000950170-24-048658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/0000950170-24-048658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/rnlx-20240424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:38:39.974082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"007eaff8bbffd6a2c05064196d3842a17957577b","claim":"Renalytix plc entered into Placing Agreement with Stifel Nicolaus Europe Limited valued at up to an aggregate of 46,801,872 ordinary shares (effective 2024-03-12).","evidence_excerpt":"on March 12, 2024, Renalytix plc (the “ Company ”) entered into a Placing Agreement (the “ Placing Agreement ”) with Stifel Nicolaus Europe Limited","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1811115/000095017024048658/0000950170-24-048658-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Stifel Nicolaus Europe Limited"},{"label":"Value","value":"up to an aggregate of 46,801,872 ordinary shares"},{"label":"Effective","value":"2024-03-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}